{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:10:10Z","timestamp":1792901410157,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10715004"],"award-info":[{"award-number":["2018ZX10715004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31571368"],"award-info":[{"award-number":["31571368"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871324"],"award-info":[{"award-number":["31871324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730064"],"award-info":[{"award-number":["81730064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.tmaid.2022.102528","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:04:14Z","timestamp":1671275054000},"page":"102528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf"],"prefix":"10.1016","volume":"52","author":[{"given":"Erik","family":"De Clercq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8852-034X","authenticated-orcid":false,"given":"Guangdi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tmaid.2022.102528_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PoH-0004-2014","article-title":"History of smallpox and its spread in human populations","volume":"4","author":"Theves","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"11","key":"10.1016\/j.tmaid.2022.102528_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/v9110331","article-title":"Poxvirus host range genes and virus-host spectrum: a critical review","volume":"9","author":"Oliveira","year":"2017","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1099","article-title":"Poxvirus tropism","volume":"3","author":"McFadden","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tmaid.2022.102528_bib4","first-page":"1","article-title":"Poxvirus-driven human diseases and emerging therapeutics","volume":"9","author":"Srinivasan Rajsri","year":"2022","journal-title":"Ther Adv Infect Dis"},{"issue":"7","key":"10.1016\/j.tmaid.2022.102528_bib5","article-title":"Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation","volume":"14","author":"Kaler","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.tmaid.2022.102528_bib6","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/v2061322","article-title":"Historical perspectives in the development of antiviral agents against poxviruses","volume":"2","author":"De Clercq","year":"2010","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/095632020801900302","article-title":"Progress in the discovery of compounds inhibiting orthopoxviruses in animal models","volume":"19","author":"Smee","year":"2008","journal-title":"Antivir Chem Chemother"},{"issue":"7\u20138","key":"10.1016\/j.tmaid.2022.102528_bib8","doi-asserted-by":"crossref","first-page":"e952","DOI":"10.1093\/milmed\/usaa084","article-title":"Reevaluating the risk of smallpox reemergence","volume":"185","author":"MacIntyre","year":"2020","journal-title":"Mil Med"},{"key":"10.1016\/j.tmaid.2022.102528_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.568412","article-title":"Vaccinia virus activation and antagonism of cytosolic DNA sensing","volume":"11","author":"El-Jesr","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmaid.2022.102528_bib10","first-page":"153","article-title":"A review on human orf: a neglected viral zoonosis","volume":"12","author":"Kassa","year":"2021","journal-title":"Res Rep Trop Med"},{"issue":"7912","key":"10.1016\/j.tmaid.2022.102528_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-022-01421-8","article-title":"Monkeypox goes global: why scientists are on alert","volume":"606","author":"Kozlov","year":"2022","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib12","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1002\/jmv.27884","article-title":"Monkeypox: a potential global threat?","volume":"94","author":"Yang","year":"2022","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41392-022-01215-4","article-title":"Monkeypox: epidemiology, pathogenesis, treatment and prevention","volume":"7","author":"Huang","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"issue":"11","key":"10.1016\/j.tmaid.2022.102528_bib14","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/infdis\/jiab133","article-title":"Clinical and epidemiological findings from enhanced monkeypox surveillance in Tshuapa Province, democratic republic of the Congo during 2011-2015","volume":"223","author":"Whitehouse","year":"2021","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.tmaid.2022.102528_bib15","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jiab135","article-title":"The evolving epidemiology of human monkeypox: questions still to Be answered","volume":"223","author":"Heymann","year":"2021","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib16","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.bja.2022.06.007","article-title":"Monkeypox and its pandemic potential: what the anaesthetist should know","volume":"129","author":"Chowdhury","year":"2022","journal-title":"Br J Anaesth"},{"issue":"10","key":"10.1016\/j.tmaid.2022.102528_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of monkeypox - West and central Africa, 1970-2017","volume":"67","author":"Durski","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41579-022-00776-z","article-title":"Monkeypox virus: a neglected zoonotic pathogen spreads globally","volume":"20","author":"Alakunle","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tmaid.2022.102528_bib19","article-title":"Human monkeypox outbreak in 2022","author":"Kumar","year":"2022","journal-title":"J Med Virol"},{"issue":"32","key":"10.1016\/j.tmaid.2022.102528_bib20","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.32.2100745","article-title":"Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021","volume":"26","author":"Hobson","year":"2021","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.tmaid.2022.102528_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - april-june 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"issue":"7913","key":"10.1016\/j.tmaid.2022.102528_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/d41586-022-01493-6","article-title":"Monkeypox outbreaks: 4 key questions researchers have","volume":"606","author":"Kozlov","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.tmaid.2022.102528_bib23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.7326\/M22-1763","article-title":"Adding new fuel to the fire: monkeypox in the time of COVID-19-implications for health care personnel","volume":"175","author":"Palmore","year":"2022","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.tmaid.2022.102528_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2022.12513","article-title":"The WHO declaration of monkeypox as a global public health emergency","volume":"328","author":"Nuzzo","year":"2022","journal-title":"JAMA"},{"issue":"35","key":"10.1016\/j.tmaid.2022.102528_bib25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.15585\/mmwr.mm7135e1","article-title":"Strategies adopted by gay, bisexual, and other men who have sex with men to prevent monkeypox virus transmission - United States, august 2022","volume":"71","author":"Delaney","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.tmaid.2022.102528_bib26","doi-asserted-by":"crossref","first-page":"taac077","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200422","article-title":"Community transmission of monkeypox in the United Kingdom, April to may 2022","volume":"27","author":"Vivancos","year":"2022","journal-title":"Euro Surveill"},{"issue":"6600","key":"10.1016\/j.tmaid.2022.102528_bib27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1126\/science.add5966","article-title":"Why monkeypox is mostly hitting men who have sex with men","volume":"376","author":"Kupferschmidt","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tmaid.2022.102528_bib28","article-title":"Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review","author":"Bragazzi","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2022.102528_bib29","article-title":"Re-emerging human monkeypox: a major public-health debacle","author":"Saxena","year":"2022","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.tmaid.2022.102528_bib30","doi-asserted-by":"crossref","first-page":"taac077","DOI":"10.1093\/jtm\/taac077","article-title":"Monkeypox 2022 outbreak: cases with exclusive genital lesions","volume":"29","author":"Davido","year":"2022","journal-title":"J Trav Med"},{"issue":"7","key":"10.1016\/j.tmaid.2022.102528_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/pathogens11070713","article-title":"Monkeypox: another sexually transmitted infection?","volume":"11","author":"Rodriguez-Morales","year":"2022","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.028","article-title":"Transmission of monkeypox virus through sexual contact - a novel route of infection","volume":"85","author":"Heskin","year":"2022","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1056\/NEJMicm2206893","article-title":"Monkeypox genital lesions","volume":"387","author":"Patrocinio-Jesus","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib34","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1016\/S2666-5247(22)00194-X","article-title":"Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions","volume":"3","author":"Ulaeto","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.tmaid.2022.102528_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature04295","article-title":"Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection","volume":"439","author":"Stittelaar","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib37","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/v14091870","article-title":"A glance at the development and patent literature of tecovirimat: the first-in-class therapy for emerging monkeypox outbreak","volume":"14","author":"Almehmadi","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102528_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01683-19","article-title":"Drug development against smallpox: present and future","volume":"64","author":"Delaune","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.tmaid.2022.102528_bib39","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3390\/v2112409","article-title":"Development of ST-246\u00ae for treatment of poxvirus infections","volume":"2","author":"Jordan","year":"2010","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.tmaid.2022.102528_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1358\/dot.2010.46.2.1437244","article-title":"Tecovirimat for smallpox infections","volume":"46","author":"Bolken","year":"2010","journal-title":"Drugs Today"},{"issue":"5","key":"10.1016\/j.tmaid.2022.102528_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/fvl.11.27","article-title":"Development of the small-molecule antiviral ST-246 as a smallpox therapeutic","volume":"6","author":"Grosenbach","year":"2011","journal-title":"Future Virol"},{"key":"10.1016\/j.tmaid.2022.102528_bib42","doi-asserted-by":"crossref","unstructured":"Siegrist E.A., Sassine J. Antivirals with activity against monkeypox: a clinically oriented review. Clin Infect Dis 2022. :ciac622. doi:10.1093\/cid\/ciac622.","DOI":"10.1093\/cid\/ciac622"},{"issue":"11","key":"10.1016\/j.tmaid.2022.102528_bib43","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1128\/AAC.00762-07","article-title":"Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.tmaid.2022.102528_bib44","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1128\/AAC.00208-15","article-title":"Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection","volume":"59","author":"Berhanu","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib45","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2019.10.049","article-title":"Co-administration of tecovirimat and ACAM2000\u2122 in non-human primates: effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge","volume":"38","author":"Russo","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.tmaid.2022.102528_bib46","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.01303-07","article-title":"Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor","volume":"52","author":"Jordan","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.tmaid.2022.102528_bib47","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification","volume":"53","author":"Jordan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tmaid.2022.102528_bib48","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"Huggins","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.tmaid.2022.102528_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antivir Res"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102528_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061514","article-title":"Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection","volume":"8","author":"Amantana","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.tmaid.2022.102528_bib51","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1128\/JVI.03426-12","article-title":"Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells","volume":"87","author":"Zaitseva","year":"2013","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.antiviral.2012.11.010","article-title":"Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246\u00ae","volume":"97","author":"Santos-Fernandes","year":"2013","journal-title":"Antivir Res"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib53","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1128\/AAC.00904-12","article-title":"Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers","volume":"56","author":"Chinsangaram","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.tmaid.2022.102528_bib54","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/AAC.00977-13","article-title":"Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox)","volume":"57","author":"Mucker","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tmaid.2022.102528_bib55","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/AAC.01689-09","article-title":"Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects","volume":"54","author":"Jordan","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib56","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/infdis\/jiy326","article-title":"Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques","volume":"218","author":"Russo","year":"2018","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.tmaid.2022.102528_bib57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.tmaid.2022.102528_bib58","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/cid\/ciz286","article-title":"Preemptive tecovirimat use in an active duty service member who presented with acute myeloid leukemia after smallpox vaccination","volume":"69","author":"Lindholm","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102528_bib59","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/AAC.01489-05","article-title":"Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures","volume":"50","author":"Lebeau","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.antiviral.2006.11.010","article-title":"In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA","volume":"75","author":"Dal Pozzo","year":"2007","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.antiviral.2009.09.012","article-title":"Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses","volume":"84","author":"Valiaeva","year":"2009","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2008.11.015","article-title":"Mousepox in the C57BL\/6 strain provides an improved model for evaluating anti-poxvirus therapies","volume":"385","author":"Parker","year":"2009","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib63","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2012.02.005","article-title":"Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox","volume":"94","author":"Parker","year":"2012","journal-title":"Antivir Res"},{"issue":"12","key":"10.1016\/j.tmaid.2022.102528_bib64","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3390\/v2122740","article-title":"Development of CMX001 for the treatment of poxvirus infections","volume":"2","author":"Lanier","year":"2010","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/v3010047","article-title":"Efficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans","volume":"3","author":"Rice","year":"2011","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.tmaid.2022.102528_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/v3020063","article-title":"Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humans","volume":"3","author":"Rice","year":"2011","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102528_bib67","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/j.tmaid.2022.102528_bib68","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/v9110320","article-title":"The role of brincidofovir in preparation for a potential smallpox outbreak","volume":"9","author":"Foster","year":"2017","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102528_bib69","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/molecules26040923","article-title":"Drug discovery of nucleos(t)ide antiviral agents: dedicated to prof. Dr. Erik De Clercq on occasion of his 80th birthday","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.tmaid.2022.102528_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114485","article-title":"Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq","volume":"185","author":"Li","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.tmaid.2022.102528_bib71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.14.2.382-397.2001","article-title":"Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections","volume":"14","author":"De Clercq","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmaid.2022.102528_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2022.102528_bib73","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0165-6147(02)02091-6","article-title":"Cidofovir in the therapy and short-term prophylaxis of poxvirus infections","volume":"23","author":"De Clercq","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2006.09.008","article-title":"Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs","volume":"73","author":"Scagliarini","year":"2007","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2022.102528_bib75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1743-422X-9-119","article-title":"A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease","volume":"9","author":"Israely","year":"2012","journal-title":"Virol J"},{"issue":"12","key":"10.1016\/j.tmaid.2022.102528_bib76","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/v2122803","article-title":"Cidofovir activity against poxvirus infections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"issue":"464","key":"10.1016\/j.tmaid.2022.102528_bib77","first-page":"467","article-title":"A novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2022.102528_bib78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"De Clercq","year":"1987","journal-title":"Antivir Res"},{"issue":"8","key":"10.1016\/j.tmaid.2022.102528_bib79","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","article-title":"Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate","volume":"49","author":"Magee","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.tmaid.2022.102528_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24050997","article-title":"Novel therapeutics for Epstein(-)Barr virus","volume":"24","author":"Andrei","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bcp.2012.03.024","article-title":"Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era","volume":"84","author":"De Clercq","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.tmaid.2022.102528_bib82","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"10.1016\/j.tmaid.2022.102528_bib83","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1135\/cccc2011065","article-title":"Acyclic nucleoside phosphonates: an unfinished story","volume":"76","author":"De Clercq","year":"2011","journal-title":"Collect Czech Chem Commun"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib84","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","article-title":"Prevention and treatment of monkeypox","volume":"82","author":"Rizk","year":"2022","journal-title":"Drugs"},{"issue":"7914","key":"10.1016\/j.tmaid.2022.102528_bib85","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/d41586-022-01587-1","article-title":"Monkeypox vaccination begins - can the global outbreaks be contained?","volume":"606","author":"Kozlov","year":"2022","journal-title":"Nature"},{"issue":"6598","key":"10.1016\/j.tmaid.2022.102528_bib86","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.add3743","article-title":"Monkeypox vaccination plans take shape amid questions","volume":"376","author":"Kupferschmidt","year":"2022","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.tmaid.2022.102528_bib87","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/infdis\/jis510","article-title":"Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001","volume":"206","author":"Lederman","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102528_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105086","article-title":"New methylene blue derivatives suggest novel anti-orthopoxviral strategies","volume":"191","author":"Priyamvada","year":"2021","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2022.102528_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113485","article-title":"Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity","volume":"221","author":"Shiryaev","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"8","key":"10.1016\/j.tmaid.2022.102528_bib90","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2174\/1567201813666161003151225","article-title":"Formulation and characterization of a ternary inclusion complex containing hydroxypropyl-\u03b2-cyclodextrin and meglumine for solubility enhancement of poorly water-soluble ST-246, an anti-smallpox drug","volume":"14","author":"Li","year":"2017","journal-title":"Curr Drug Deliv"},{"issue":"8","key":"10.1016\/j.tmaid.2022.102528_bib91","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat Med"},{"issue":"6619","key":"10.1016\/j.tmaid.2022.102528_bib92","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.add4153","article-title":"Multiple lineages of monkeypox virus detected in the United States, 2021-2022","volume":"378","author":"Gigante","year":"2022","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.tmaid.2022.102528_bib93","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1056\/NEJMra020025","article-title":"Diagnosis and management of smallpox","volume":"346","author":"Breman","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tmaid.2022.102528_bib94","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S1413-86702010000200003","article-title":"Clinical signs, diagnosis, and case reports of Vaccinia virus infections","volume":"14","author":"Silva","year":"2010","journal-title":"Braz J Infect Dis"},{"issue":"5","key":"10.1016\/j.tmaid.2022.102528_bib95","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/infdis\/jiq103","article-title":"Evaluation of therapeutic interventions for vaccinia virus keratitis","volume":"203","author":"Altmann","year":"2011","journal-title":"J Infect Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922002745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922002745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:09:32Z","timestamp":1761487772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893922002745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":95,"alternative-id":["S1477893922002745"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102528","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102528"}}